Upadacitinib |
乌帕替尼 |
1310726-60-3 |
Methyl 2-[(1H-pyrrolo[2,3-b]pyridin-5-yl)oxy]-4-[4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohex-1-enyl]methyl]piperazin-1-yl]benzoate |
2-[(1H-吡咯并[2,3-B]吡啶-5-基)氧基]-4-[4-[[2-(4-氯苯基)-4,4-二甲基环己-1-烯基]甲基]哌嗪-1-基]苯甲酸甲酯 |
1235865-76-5 |
Methyl 4-Fluoro-2-{1H-pyrrolo[2,3-b]pyridin-5-yloxy}benzoate |
ABT-199中间体 |
1235865-75-4 |
(R)-3-(4-phenoxyphenyl)-1-(piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine dihydrochloride |
3-(4-苯氧基苯基)-1-(3R)-3-哌啶基-1H-吡唑并[3,4-D]嘧啶-4-胺盐酸盐(1:2) |
1701403-10-2 |
Valbenazine tosylate |
結苯那嗪 |
1639208-54-0 |
Chemtrue-RL-N5 |
2-[(2 ,6-二氟苄基)乙氧基羰基氨基]-4-((二甲基氨基)甲基)-5-(4-硝基苯基)噻吩-3-甲酸乙酯 |
1589503-97-8 |
2-((2,6-difluorobenzyl)(ethoxycarbonyl)amino)-4-((dimethylamino)methyl)-5-(4-nitrophenyl)thiophene-3-carboxylic acid |
2-((2,6-二氟苄基)(乙氧基羰基)氨基)-4-((二甲基氨基)甲基)-5-(4-硝基苯基)噻吩-3-羧酸 |
1589503-95-6 |
Treprostinil intermediate 1 |
[(4S)-4-羟基壬基]膦酸二甲酯 |
1593674-47-5 |
BMS-986165 |
BMS-986165 |
1609392-27-9 |
4-cyclopropylnaphthalen-1-aMine hydrochloride |
1-环丙基-4-萘胺盐酸盐 |
1533519-92-4 |
Lemborexant |
莱博雷生 |
1369764-02-2 |
BMN 673 (8R,9S) |
(8R,9S)-5-氟-8-(4-氟苯基)-2,7,8,9-四氢-9-(1-甲基-1H-1,2,4-三唑-5-基)-3H-吡啶并[4,3,2-DE]酞嗪-3-酮 |
1207456-00-5 |
Filgotinib |
非戈替尼 |
1206161-97-8 |
(2S,4R)-5-(Biphenyl-4-yl)-4-[(tert-butoxycarbonyl)amino]-2-methylpentanoic acid |
(2S,4R)-5-(联苯基-4-基)-4-[(叔丁氧羰基)氨基]-2-甲基戊酸 |
1012341-54-6 |
(2R,4S)-5-([1,1'-biphenyl]-4-yl)-4-((tert-butoxycarbonyl)aMino)-2-Methylpentanoic acid |
(2R,4S)-5-(联苯-4-基)-4-[(叔丁氧基羰基)氨基]-2-甲基戊酸 |
1012341-50-2 |
(R,E)-5-([1,1'-biphenyl]-4-yl)-4-((tert-butoxycarbonyl)aMino)-2-Methylpent-2-enoic acid |
(R,E)-5-([1,1'-联苯]-4-基)-4-((叔丁氧羰基)氨基)-2-甲基-2-戊烯酸 |
1012341-48-8 |
D-xylo-Pentodialdo-5,2-furanose, 1-C-[4-chloro-3-[(4-ethoxyphenyl)Methyl]phenyl]-4,5-O-(1-Methylethylidene)-,(5S)- |
LX4211 N-4中间体 |
1103738-30-2 |
Cabotegravir (GSK744, GSK1265744) |
卡博特韦 |
1051375-10-0 |
4-(4-Cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxamide |
1050477-27-4 |
1050477-27-4 |
Finerenone (BAY 94-8862) |
非奈利酮 |
1050477-31-0 |